Top of this page
Skip navigation, go straight to the content

This section is intended for media and financial analysts
Newsroom Press Releases

UCB Group - Provisional Results for 2003: Increase in Net Profit.

pdf english pdf french pdf nederlands

February 4th, 2004

  • Estimated net profit after tax is € 337 million, which represents an increase of 2% at actual exchange rates and more than 21% at constant exchange rates.
  • Ordinary profit is € 480 million, 3% down on the record year of 2002 at actual exchange rates, an increase of 16% at constant exchange rates. Ordinary profit for the Pharma Sector is € 401 million and represents 84 % of the Group's ordinary profit.
  • The UCB Group has generated a consolidated turnover for 2003 of € 2,965 million and an operating profit (EBIT) of € 487 million.
  • The evolution of the exchange rates had a € 92 million impact on ordinary profit.

Stay up-to-date on the latest news and information from UCB